1. Home
  2. JEQ vs NSPR Comparison

JEQ vs NSPR Comparison

Compare JEQ & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JEQ
  • NSPR
  • Stock Information
  • Founded
  • JEQ 1990
  • NSPR 2005
  • Country
  • JEQ United States
  • NSPR United States
  • Employees
  • JEQ N/A
  • NSPR N/A
  • Industry
  • JEQ Air Freight/Delivery Services
  • NSPR Medical/Dental Instruments
  • Sector
  • JEQ Consumer Discretionary
  • NSPR Health Care
  • Exchange
  • JEQ Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • JEQ 88.1M
  • NSPR 75.1M
  • IPO Year
  • JEQ N/A
  • NSPR N/A
  • Fundamental
  • Price
  • JEQ $7.13
  • NSPR $2.44
  • Analyst Decision
  • JEQ
  • NSPR Strong Buy
  • Analyst Count
  • JEQ 0
  • NSPR 2
  • Target Price
  • JEQ N/A
  • NSPR $4.50
  • AVG Volume (30 Days)
  • JEQ 32.0K
  • NSPR 45.0K
  • Earning Date
  • JEQ 01-01-0001
  • NSPR 08-05-2025
  • Dividend Yield
  • JEQ 7.05%
  • NSPR N/A
  • EPS Growth
  • JEQ N/A
  • NSPR N/A
  • EPS
  • JEQ N/A
  • NSPR N/A
  • Revenue
  • JEQ N/A
  • NSPR $7,027,000.00
  • Revenue This Year
  • JEQ N/A
  • NSPR $27.41
  • Revenue Next Year
  • JEQ N/A
  • NSPR $127.08
  • P/E Ratio
  • JEQ N/A
  • NSPR N/A
  • Revenue Growth
  • JEQ N/A
  • NSPR 8.49
  • 52 Week Low
  • JEQ $4.99
  • NSPR $2.07
  • 52 Week High
  • JEQ $6.39
  • NSPR $3.80
  • Technical
  • Relative Strength Index (RSI)
  • JEQ 52.12
  • NSPR 50.84
  • Support Level
  • JEQ $7.08
  • NSPR $2.40
  • Resistance Level
  • JEQ $7.87
  • NSPR $2.59
  • Average True Range (ATR)
  • JEQ 0.12
  • NSPR 0.11
  • MACD
  • JEQ -0.03
  • NSPR 0.00
  • Stochastic Oscillator
  • JEQ 5.70
  • NSPR 57.50

About JEQ abrdn Japan Equity Fund Inc.

Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: